Jiangxi Sanxin Medtec Co.,Ltd. (SHE:300453)

Jiangxi Sanxin Medtec Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Income	290.24	264.94	227.4	206.63	184.63	155.91
Depreciation & Amortization	120.29	120.29	90.73	74.49	65.76	57.85
Other Amortization	2.39	2.39	0.36	3.77	5.75	3.35
Loss (Gain) From Sale of Assets	0.85	0.85	-0.19	-0.16	-0.01	0.89
Asset Writedown & Restructuring Costs	1.69	1.69	1.1	0.38	7.68	5.2
Loss (Gain) From Sale of Investments	-10.64	-10.64	0.78	-11.08	-4.63	-1.07
Provision & Write-off of Bad Debts	4.18	4.18	4.03	0.82	-	-
Other Operating Activities	-34.32	32.39	24.83	22.37	17.78	18.23
Change in Accounts Receivable	-19.47	-19.47	28.52	-9.37	20.18	-33.42
Change in Inventory	-11.15	-11.15	3.33	-4.73	-40.59	-10.82
Change in Accounts Payable	68.75	68.75	10.09	48.95	117.15	125.01
Change in Other Net Operating Assets	11.74	11.74	7.84	8.32	24.7	9.81
Operating Cash Flow	419.19	460.6	389.59	339.81	402.18	329.72
Operating Cash Flow Growth	7.10%	18.23%	14.65%	-15.51%	21.98%	20.82%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Capital Expenditures	-253.21	-241.87	-217.54	-287.47	-210.55	-174.8
Sale of Property, Plant & Equipment	0.46	0.65	1.39	0.5	0.02	0.06
Investment in Securities	-114.3	74.01	21.24	-139.62	-169.5	109.06
Other Investing Activities	7.92	11.84	8.5	7.16	4.38	1.98
Investing Cash Flow	-359.13	-155.36	-186.4	-419.43	-375.65	-63.7

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Short-Term Debt Issued	-	-	-	-	-	102
Long-Term Debt Issued	-	81.34	190.23	205.93	392.14	-
Total Debt Issued	584.53	81.34	190.23	205.93	392.14	102
Short-Term Debt Repaid	-	-	-	-	-	-177.33
Long-Term Debt Repaid	-	-70.9	-155.96	-130.69	-304	-
Lease Payments	-1.51	-1.51	-1.08	-	-	-
Total Debt Repaid	-56.39	-70.9	-155.96	-130.69	-304	-177.33
Net Debt Issued (Repaid)	528.14	10.44	34.27	75.24	88.14	-75.33
Issuance of Common Stock	1	1	41.48	14.19	21.02	-
Repurchase of Common Stock	-0.97	-0.97	-43.45	-	-	-
Common Dividends Paid	-164.18	-163.29	-131.99	-63.99	-71.41	-53.98
Other Financing Activities	-10.83	-15.49	-23.9	-34.62	-2.32	-5.01
Financing Cash Flow	353.16	-168.31	-123.59	-9.18	35.43	-134.32

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Foreign Exchange Rate Adjustments	-2.91	1.31	2.96	0.76	1.57	-1.78
Net Cash Flow	410.31	138.24	82.55	-88.04	63.53	129.92

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Free Cash Flow	165.98	218.73	172.05	52.34	191.62	154.91
Free Cash Flow Growth	18.17%	27.13%	228.72%	-72.69%	23.70%	-11.36%
Free Cash Flow Margin	9.34%	13.34%	11.47%	4.03%	14.34%	13.31%
Free Cash Flow Per Share	0.32	0.42	0.33	0.10	0.37	0.30
Levered Free Cash Flow	87.03	113.17	106.64	-67.76	62.94	60.55
Unlevered Free Cash Flow	89.22	114.31	108.59	-64.93	64.78	61.85
Free Cash Flow After Leases	164.48	217.23	170.97	52.34	191.62	154.91

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash Income Tax Paid	95.12	87.94	73.73	65.82	63.17	79.45
Change in Working Capital	44.51	44.51	40.55	42.58	125.22	89.35

Data Source: S&P Global Market Intelligence Last updated: Oct 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error